Iodine: deficiency and therapeutic considerations.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data.
What was done
This narrative review summarizes the clinical consequences of iodine deficiency (such as goiter, hypothyroidism, and fetal neurodevelopmental impairment), discusses the safety profile of high iodine consumption based on Japanese population dietary intake, and examines potential therapeutic uses of iodine in fibrocystic breast disease and antioxidant physiology.
What was found
The abstract reports descriptive observations rather than primary trial data. It notes that the Japanese population consumes approximately 25 times the median US intake of iodine without a demonstrable rise in autoimmune thyroiditis or hypothyroidism, and references studies where 3.0 to 6.0 mg doses were used to treat fibrocystic breast disease.
Why it matters
It highlights the broader physiological roles of iodine beyond basic thyroid hormone synthesis, including potential extrathyroidal functions in breast tissue architecture.
Limits
The paper is a non-systematic narrative review. The abstract lacks specific study designs, sample sizes, confidence intervals, and quantitative effect estimates. Population-level dietary comparisons between Japan and the United States are ecological and prone to substantial confounding.
Cited by
- context Iodine buffers excess estrogen and acts as an effective remedy to treat and prevent fibrocystic breast condition, ovarian cysts, fibroids, and endometriosis.